Related Experiment Videos
Malignant neuroblastic tumors in adolescents
Massimo Conte1, Bruno De Bernardi, Claudia Milanaccio
1Department of Haematology/Oncology, Scientific Directorate, Giannina Gaslini Children's Hospital, Genova, Italy.
Cancer Letters
|May 27, 2005
Summary
Malignant neuroblastic tumors (MNT) in adolescents present uniquely, often diagnosed at advanced stages with unusual metastasis sites. Standard pediatric treatments yield poor survival, indicating a need for tailored adolescent care.
Area of Science:
- Pediatric Oncology
- Adolescent Medicine
- Cancer Biology
Background:
- Malignant neuroblastic tumors (MNT) are common in young children but rare in adolescents.
- Clinical characteristics and outcomes of MNT in adolescents remain poorly understood.
Purpose of the Study:
- To review and summarize clinical reports on MNT in adolescents.
- To compare MNT presentation and outcomes in adolescents versus children.
Main Methods:
- Literature review of clinical reports on MNT in adolescents.
- Inclusion of original data for comprehensive analysis.
Main Results:
- Adolescent MNT are frequently diagnosed at advanced stages with uncommon metastatic sites.
- Unfavorable biological markers are less common in adolescent MNT compared to pediatric cases.
- Standard pediatric treatment protocols result in poor survival for adolescents.
Conclusions:
- Adolescent MNT exhibit distinct clinical features and aggressive behavior, even in localized disease.
- Current treatment strategies for pediatric MNT are inadequate for adolescents, necessitating specialized approaches.